tetradecanoylphorbol acetate has been researched along with epirubicin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davey, MW; Davey, RA; Kidman, AD; Marks, DC | 1 |
Ala, U; Brusa, D; Calautti, E; Magnuson, MA; Neri, F; Oliviero, S; Provero, P; Riganti, C; Saoncella, S; Tassone, B | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and epirubicin
Article | Year |
---|---|
Expression of multidrug resistance in response to differentiation in the K562 human leukaemia cell line.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Butyrates; Butyric Acid; Cell Differentiation; Cell Survival; Colchicine; Drug Resistance, Multiple; Epirubicin; Humans; Leukemia; Phenotype; Rhodamine 123; Rhodamines; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Verapamil | 1995 |
Rictor/mTORC2 deficiency enhances keratinocyte stress tolerance via mitohormesis.
Topics: Acetylcysteine; Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Cellular Senescence; Epirubicin; Glutamic Acid; Hyperplasia; Keratin-14; Keratinocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Radiation Tolerance; Rapamycin-Insensitive Companion of mTOR Protein; Reactive Oxygen Species; Skin; Tetradecanoylphorbol Acetate; Transcriptome; X-Rays | 2017 |